Year |
Citation |
Score |
2019 |
Wu W, Donoho G, Iversen P, Dempsey J, Capen A, Castanares M, Stephens J, Boehnke K, Reinhard CR, Lin A. Abstract 3508: Combination of the Chk1 inhibitor (prexasertib) with a PI3K/mTOR inhibitor (LY3023414) induces synergistic anti-tumor activity in triple negative breast cancer (TNBC) models Cancer Research. 79: 3508-3508. DOI: 10.1158/1538-7445.Am2019-3508 |
0.379 |
|
2018 |
Wu W, King C, Donoho G, Iversen P, Capen A, Castanares M, Stephens J, Ding Y, Pratt S, Martinez R, Buchanan S, Reinhard C, Beckmann R, Lin A. Abstract 336: Anti-tumor activity of the Chk1 inhibitor prexasertib (LY2606368) as a single agent in triple negative breast cancer models Cancer Research. 78: 336-336. DOI: 10.1158/1538-7445.Am2018-336 |
0.342 |
|
2015 |
Castanares MA, Copeland BT, Chowdhury WH, Liu MM, Rodriguez R, Pomper MG, Lupold SE, Foss CA. Characterization of a novel metastatic prostate cancer cell line of LNCaP origin. The Prostate. PMID 26499105 DOI: 10.1002/Pros.23115 |
0.526 |
|
2015 |
Ni X, Zhang Y, Zennami K, Castanares M, Mukherjee A, Raval RR, Zhou H, DeWEese TL, Lupold SE. Systemic administration and targeted radiosensitization via chemically synthetic aptamer-siRNA chimeras in human tumor xenografts. Molecular Cancer Therapeutics. PMID 26438155 DOI: 10.1158/1535-7163.Mct-15-0291-T |
0.395 |
|
2015 |
Neuman BP, Eifler JB, Castanares M, Chowdhury WH, Chen Y, Mease RC, Ma R, Mukherjee A, Lupold SE, Pomper MG, Rodriguez R. Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 771-80. PMID 25501577 DOI: 10.1158/1078-0432.Ccr-14-0891 |
0.603 |
|
2014 |
Castanares MA, Mukherjee A, Chowdhury WH, Liu M, Chen Y, Mease RC, Wang Y, Rodriguez R, Lupold SE, Pomper MG. Evaluation of prostate-specific membrane antigen as an imaging reporter. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 805-11. PMID 24700883 DOI: 10.2967/Jnumed.113.134031 |
0.539 |
|
2013 |
Neuman BP, Eifler JB, Castanares M, Chowdhury WH, Chen Y, Pomper MG, Rodriguez R. Abstract 3919: A preclinical model of laparoscopy demonstrating the feasibility of detecting PSMA positive cells with a NIR fluorophore (YC-27): implications for strategies to decrease positive margins during prostatectomy. Cancer Research. 73: 3919-3919. DOI: 10.1158/1538-7445.Am2013-3919 |
0.52 |
|
2013 |
Neuman B, Eifler J, Castanares M, Chowdhury W, Chen Y, Pomper M, Rodriguez R. 1319 A NEAR-INFRARED IMAGING AGENT IDENTIFIES PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITIVE CELLS DURING LAPAROSCOPIC SURGERY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2673 |
0.544 |
|
2011 |
Ni X, Castanares M, Mukherjee A, Lupold SE. Nucleic acid aptamers: Clinical applications and promising new horizons Current Medicinal Chemistry. 18: 4206-4214. PMID 21838685 DOI: 10.2174/092986711797189600 |
0.309 |
|
2011 |
Ni X, Zhang Y, Ribas J, Chowdhury WH, Castanares M, Zhang Z, Laiho M, DeWeese TL, Lupold SE. Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. The Journal of Clinical Investigation. 121: 2383-90. PMID 21555850 DOI: 10.1172/Jci45109 |
0.465 |
|
2011 |
Ni X, Zhang Y, Ribas J, Chodhury WH, Castanares M, Zhang Z, Laiho M, DeWeese TL, Lupold SE. Abstract 5387: Prostate-targeted radiosensitization via aptamer-shRNA chimeras Cancer Research. 71: 5387-5387. DOI: 10.1158/1538-7445.Am2011-5387 |
0.422 |
|
2011 |
Eifler J, Chowdhury W, Castanares M, Foss C, George N, Pomper M, Rodriguez R. V1221 INTRAOPERATIVE USE OF A PROSTATE SPECIFIC MEMBRANE ANTIGEN-BASED FLUORESCENT IMAGING AGENT FOR PROSTATE CANCER IN A MOUSE MODEL Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.879 |
0.584 |
|
2011 |
Eifler J, Chowdhury W, Foss C, Castanares M, Chen Y, George N, Pomper M, Rodriguez R. 1623 A FLUORESCENT IMAGING AGENT SPECIFICALLY TARGET PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CELLS Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1731 |
0.561 |
|
2010 |
Höti N, Chowdhury WH, Mustafa S, Ribas J, Castanares M, Johnson T, Liu M, Lupold SE, Rodriguez R. Armoring CRAds with p21/Waf-1 shRNAs: The next generation of oncolytic adenoviruses Cancer Gene Therapy. 17: 585-597. PMID 20448671 DOI: 10.1038/Cgt.2010.15 |
0.427 |
|
2008 |
Chen Y, Foss CA, Byun Y, Nimmagadda S, Pullambhatla M, Fox JJ, Castanares M, Lupold SE, Babich JW, Mease RC, Pomper MG. Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer. Journal of Medicinal Chemistry. 51: 7933-43. PMID 19053825 DOI: 10.1021/Jm801055H |
0.554 |
|
2008 |
Barinka C, Byun Y, Dusich CL, Banerjee SR, Chen Y, Castanares M, Kozikowski AP, Mease RC, Pomper MG, Lubkowski J. Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: Structural characterization Journal of Medicinal Chemistry. 51: 7737-7743. PMID 19053759 DOI: 10.1021/Jm800765E |
0.451 |
|
2008 |
Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ, Hilton J, Lupold SE, Kozikowski AP, Pomper MG. Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) Journal of Medicinal Chemistry. 51: 4504-4517. PMID 18637669 DOI: 10.1021/Jm800111U |
0.561 |
|
Show low-probability matches. |